shutterstock_25056481.jpg

Corona vaccine COVID-19

We are currently developing our own vaccine against COVID-19, our vaccine is based on a Human cell line platform expressing structural glycoproteins with Immunogenic carrier VLPs. Virus-like particles (VLPs) are molecules closely resembling viruses, thus rendering an immunogenic response other viral vaccines are producing.

We have long experience of developing similar corona virus based on SARS vaccine within a short time period. We are fully confident our own new coronavirus vaccine will have the same SAFE approach.